Root Financial Partners’s Bright Minds Biosciences DRUG Stock Holding History

Root Financial Partners’s Portfolio DRUG Stock Details DRUG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$50	Buy	+1	New	+$71	﹤0.01%	3720

Other funds holding DRUG

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

Rydar Equities Weatherford, Texas $194M AUM 23.21% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Root Financial Partners's DRUG Position: Q3 2026 in Review

Root Financial Partners opened a new position in Bright Minds Biosciences (DRUG) in Q3 2026: 1 share worth $50. The stake represents ﹤0.01% of the portfolio and ranks #3720 among its holdings.

9 funds tracked by Wall St. Rank hold DRUG as of Q3 2026.

Root Financial Partners held 1 share of Bright Minds Biosciences worth $50 as of Q3 2026.
Bright Minds Biosciences was a new Root Financial Partners position in Q3 2026.
Bright Minds Biosciences made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #3720 holding.
9 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.